N syndrome

Search Trials
Niacin, N-3 Fatty Acids and Insulin Resistance
Status:
Completed
Last Changed:
Jan 5, 2013
First Changed:
Mar 2, 2006
Disease(s):
Metabolic Syndrome
Intervention(s):
omega-3 acid ethyl estersextended release niacinplaceboomega-3 acid ethyl esterscombined treatment
Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Systemic Lupus
Intervention(s):
Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus)
Effect of Fish Oil on Markers of the Metabolic Syndrome in Overweight Adolescent Boys
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Metabolic Syndrome
Intervention(s):
Dietary oils (fish, vegetable oil)
Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses
Status:
Completed
Last Changed:
Nov 12, 2012
First Changed:
Nov 12, 2012
Disease(s):
Dry Eye Syndrome
Intervention(s):
Chitosan-N-acetylcysteine eye drops (concentration of 0.1%)Physiological saline solution
Transcriptomic Profile of Adipose Tissue Following n-3 Polyunsaturated Fatty Acid (PUFA) Supplementation
Status:
Completed
Last Changed:
Jun 9, 2010
First Changed:
Jun 9, 2010
Disease(s):
Polycystic Ovary Syndrome
Intervention(s):
LC n-3 PUFA (fish oil) Supplement

Connect. Empower. Inspire.